The Value of Serum FGF19 and GDF15 in Evaluating the Prognosis of Patients with Liver Cancer Undergoing Interventional Therapy

The Value of Serum FGF19 and GDF15 in Evaluating the Prognosis of Patients with Liver Cancer Undergoing Interventional Therapy

JIANG Fuqiang, XIE Peng, ZHANG Jiacheng, DU Peng, ZHANG Zhe

PDF(1251 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1251 KB)

Labeled Immunoassays and Clinical Medicine ›› 2024, Vol. 31 ›› Issue (2) : 203-207. DOI: 10.11748/bjmy.issn.1006-1703.2024.02.002

Clinical Investigation

The Value of Serum FGF19 and GDF15 in Evaluating the Prognosis of Patients with Liver Cancer Undergoing Interventional Therapy

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 31(2): 203-207 https://doi.org/10.11748/bjmy.issn.1006-1703.2024.02.002

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1251 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉